首页> 外文OA文献 >The A lzheimer's disease THE rapy with NE uroaid ( ATHENE ) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild‐to‐moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double‐blind, placebo‐controlled trial

【2h】

The A lzheimer's disease THE rapy with NE uroaid ( ATHENE ) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild‐to‐moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double‐blind, placebo‐controlled trial

机译：Lzheimer的疾病与Ne Uroaid（Athene）的研究方案的脱脂剂：评估神经外套II（MLC901）在胆碱酯酶抑制剂或Memantine-A随机的双盲患者稳定的患者中神经外套II（MLC901）的安全性和有效性安慰剂对照试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Christopher L.H. Chen; Purabi Reang Sharma; Boon Yeow Tan; Casuarine Low; Narayanaswamy Venketasubramanian;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. The safety, tolerability, and efficacy of once-daily memantine (28 mg): A multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe alzheimer's disease taking cholinesterase inhibitors [J] . GrossbergG.T., ManesF., AllegriR.F., CNS drugs . 2013,第6期

机译：每日一次美金刚（28 mg）的安全性，耐受性和疗效：一项针对胆碱酯酶抑制剂的中重度阿尔茨海默氏病患者的多国，随机，双盲，安慰剂对照试验
2. Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study [J] . Florian Hana, Meier Andreas, Gauthier Serge, Journal of Alzheimer's disease: JAD . 2016,第4期

机译：ABT-126对轻度至中度阿尔茨海默氏病患者乙酰胆碱酯酶抑制剂稳定剂量的疗效和安全性：一项随机，双盲，安慰剂对照的研究
3. Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: Results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan [J] . NakamuraY., KitamuraS., HommaA., Expert opinion on pharmacotherapy . 2014,第7期

机译：美金刚对中度至重度阿尔茨海默氏病患者的疗效和安全性：日本两项随机，双盲，安慰剂对照试验的汇总分析结果
4. A Randomized, Placebo-Controlled Study of the Efficacy of Cognitive Intervention on Elderly People and on Patient's with Alzheimer's Disease [C] . J.J. Yanguas, C. Buiza, I. Etxeberria, International Conference on Computers Helping People with Special Needs(ICCHP 2006); 20060711-13; Linz(AT) . 2006

机译：认知干预对老年人和阿尔茨海默氏病患者疗效的随机，安慰剂对照研究
5. Assessing the Safety of Cholinesterase Inhibitor Discontinuation in Patients with Moderate to Severe Alzheimer's Disease in a Long Term Care Setting. [D] . O'Regan, Jordana. 2014

机译：在长期护理环境中评估中度至重度阿尔茨海默氏病患者停用胆碱酯酶抑制剂的安全性。
6. The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double-blind, placebo-controlled trial [O] . Christopher L.H. Chen, Purabi Reang Sharma, Boon Yeow Tan, 2015

机译：NEuroaid（ATHENE）研究阿尔茨海默氏病的研究方案：评估神经碱II（MLC901）在胆碱酯酶抑制剂或美金刚稳定的轻度至中度阿尔茨海默氏病患者中的安全性和有效性-随机，双盲，安慰剂对照试用
7. The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors [O] . George T. Grossberg, Facundo Manes, Ricardo F. Allegri, 2013

机译：每日一次美金刚胺（28 mg）的安全性，耐受性和功效：接受胆碱酯酶抑制剂的中重度阿尔茨海默氏病患者的多国，随机，双盲，安慰剂对照试验

The A lzheimer's disease THE rapy with NE uroaid ( ATHENE ) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild‐to‐moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double‐blind, placebo‐controlled trial

著录项

引文网络

相似文献

相关主题

期刊订阅